The pathologic conditions of atherosclerosis and coronary heart disease are secondary to hyperlipidemia and particularly hypercholesterolemia. While the disorder is greatly enhanced by the consumption of high fat diets in the Western world, individuals are also genetically predisposed to the development of the atherogenic conditions which are multifactorial in nature. Regardless of the underlying genetic causes however, transgenic animal studies have demonstrated that enhanced hepatic expression of the LDL receptor and apolipoprotein A1 genes suppressed plasma LDL cholesterol and elevated plasma HDL cholesterol levels in normal animals, respectively. We propose that these desirable biochemical phenotypes in plasma can also be achieved by somatic delivery of the plasma lipid modulating genes into the liver. Our laboratory has recently demonstrated that hepatocytes can be transduced in vivo with recombinant retroviral vectors by direct fusion into the portal vein of partially hepatectomized mice, which resulted in persistent expression of the recombinant genes for at least 6 months in the recipients. In addition, we have obtained preliminary evidence that hepatocytes can be very efficiently transduced in vivo with recombinant adenoviral vectors by interportal vein injection with no apparent hepatic pathology in mice. Furthermore, recombinant genes coupled with ligands for hepato-specific receptors can be introduced into hepatocytes quantitatively by receptor mediated endocytosis. All of these technologies will be further developed and applied in the direct delivery of the LDL receptor gene into the liver of Watanabe hereditary hyperlipidemic rabbits which are genetically predisposed to atherosclerosis due to LDL receptor deficiency. In addition to this and other genetic animal models created by Project 1, the dietary model of atherosclerosis will also be tested. The heterozygous Watanabe rabbits are predisposed to hypercholesterolemia and vascular plaque development when fed a high fat diet. In addition to LDL receptor, other therapeutic genes such as apolipoprotein A-1 and cholesterol-7a-hydroxylase will also be delivered to the liver of these animals maintained on such atherosclerosis-inducing diets. Successful correction of the biochemical and pathologic phenotype in these genetic and dietary animal model systems by direct hepatic gene transfer will form the scientific basis for further gene therapy of atherosclerosis and coronary heart disease in man.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
1P01HL050422-01
Application #
3781169
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Waugh, J M; Li-Hawkins, J; Yuksel, E et al. (2000) Thrombomodulin overexpression to limit neointima formation. Circulation 102:332-7
Waugh, J M; Yuksel, E; Li, J et al. (1999) Local overexpression of thrombomodulin for in vivo prevention of arterial thrombosis in a rabbit model. Circ Res 84:84-92
Waugh, J M; Kattash, M; Li, J et al. (1999) Gene therapy to promote thromboresistance: local overexpression of tissue plasminogen activator to prevent arterial thrombosis in an in vivo rabbit model. Proc Natl Acad Sci U S A 96:1065-70
Rojas-Martinez, A; Wyde, P R; Montgomery, C A et al. (1998) Distribution, persistency, toxicity, and lack of replication of an E1A-deficient adenoviral vector after intracardiac delivery in the cotton rat. Cancer Gene Ther 5:365-70
Faith, R E; Montgomery, C A; Durfee, W J et al. (1997) The cotton rat in biomedical research. Lab Anim Sci 47:337-45
Gottschalk, S; Sparrow, J T; Hauer, J et al. (1996) A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells. Gene Ther 3:448-57
Guo, Z S; Wang, L H; Eisensmith, R C et al. (1996) Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer. Gene Ther 3:802-10
Gingras, M C; Arevalo, P; Aguilar-Cordova, E (1996) Potential salmon sperm origin of the E3 region insert of the adenovirus 5 dl309 mutant. Cancer Gene Ther 3:151-4
Sparrow, J T; Monera, O D (1996) Improvements to the TMSBr method of peptide resin deprotection and cleavage: application to large peptides. Pept Res 9:218-22
Gottschalk, S; Tweten, R K; Smith, L C et al. (1995) Efficient gene delivery and expression in mammalian cells using DNA coupled with perfringolysin O. Gene Ther 2:498-503

Showing the most recent 10 out of 13 publications